stockrowProgyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Shares outstanding
Progyny, Inc.'s shares outstanding at the end of fiscal 2025 was $89.9M, down 5.85% from $95.4M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $81.2M. Over the past ten years it has ranged from $5.5M (fiscal 2018) to $100.7M (fiscal 2023); the current reading is higher than 44% of that period. Progyny, Inc. ranks 10th of 12 Healthcare Plans companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $89.9M | (5.85%) |
| FY2024 | $95.4M | (5.19%) |
| FY2023 | $100.7M | 0.72% |
| FY2022 | $100.0M | (0.40%) |
| FY2021 | $100.4M | 1.31% |
| FY2020 | $99.1M | 377.72% |
| FY2019 | $20.7M | 274.28% |
| FY2018 | $5.5M | (2.43%) |
| FY2017 | $5.7M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $81.2M | (1.18%) |
| Jun 2026 | $82.1M | (3.08%) |
| Mar 2026 | $84.8M | (5.68%) |
| Dec 2025 | $89.9M | (0.40%) |
| 28 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CLOV Clover Health Investments, Corp. compare | $557.5M |
| CNC Centene Corporation compare | $494.1M |
| OSCR Oscar Health, Inc. compare | $346.5M |
| CI Cigna Group compare | $263.8M |
| ELV Elevance Health, Inc. compare | $217.6M |
| ALHC Alignment Healthcare, Inc. compare | $208.6M |
| HUM Humana Inc. compare | $121.8M |
| PGNY Progyny, Inc. | $81.2M |
| MOH Molina Healthcare, Inc compare | $51.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement